Gerresheimer expands its plastic pharmaceutical packaging business in the US and Europe
Gerresheimer, the German pharmaceutical packaging group, has expanded its activities with two investments in the US and Europe.
Gerresheimer, the German pharmaceutical packaging group, has expanded its activities with two investments in the US and Europe.
The company has opened a new research and development centre for medical plastic systems in the US, as well as a pharmaceutical plastic packaging plant in Spain.
"Plastics are increasingly gaining in importance within our highly specialised service portfolio for the international pharmaceutical industry," says Gerresheimer's ceo Dr Axel Herberg.
"The pharmaceutical plastic business has meanwhile become the division with the highest growth rate, which we are continuing to expand systematically. These are crucial investments in the Gerresheimer Group's growth."
The company says the US r&d centre in Peachtree City, Georgia will open up a "new dimension" for its clients in the pharmaceutical, diagnostics and medical technology sectors. The US location, which has until recently been limited to manufacturing, has been upgraded to become a full r&d and production centre. Products include inhalation systems for the treatment of respiratory diseases, as well as insulin pen systems, skin-prick aids and lancets for the diabetes sector, which is also growing steadily.
The company says the new European plant opened in Masalaves, Spain, which produces bottles and multifunctional dosage and closure systems for eye drops, contact lens care products and nasal sprays, as well as tablets, is also "highly significant".
The company's plastics packaging business now has operations in 15 locations in Europe, America and Asia. Both segments of the plastics division are continuing to attain above average growth rates and account for a third of group sales, which were Euro 1.06bn in 2008.